Work

Figure S2 from Topical Resiquimod Elicits Systemic Protection and Improves Anti–PD-1 Therapy in Melanoma via Priming of CD8+ T Cells

Year: 2026

Type: other

Abstract: Supplementary Figure 2. Cytokine expression in Tyr::creER, Brafca, Ptenlox/lox mouse tumors after resiquimod treatment.

DOI: 10.1158/2326-6066.33414300

Authors: Shujing Liu, Alain H. Rook, Alexander C. Huang, Amit Maity, Zhiyuan Qin, Yeqing Chen, Delu Song, Yanxiang Deng, Zhi Huang, Giorgos C. Karakousis, Tara C. Mitchell, Ravi K. Amaravadi, Lynn M. Schuchter, Zev A. Binder, Donald M. O’Rourke, Meenhard Herlyn, Wei Guo, Xiaowei Xu

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7205008524

Cites:

Cited by:

Related to: